Report Library

All Reports
Datamonitor Healthcare Oncology: NHL: Peripheral T-Cell Lymphoma (PTCL) Market Spotlight

November 24, 2022

Peripheral T-cell lymphoma (PTCL) includes a diverse group of generally aggressive and rare non-Hodgkin’s lymphomas (NHLs) that develop from mature T-cells. Generally, PTCL affects individuals aged above 60 years, and is slightly more common in males than in females. The first signs and symptoms of PTCL vary based on the disease subtype. Common symptoms include painless and enlarged lymph nodes in the armpit, neck, or groin; nausea; vomiting and/or diarrhea; abdominal pain; rash; and an enlarged liver and spleen. Other symptoms of PTCL include fever, weight loss, and night sweats. 

This Datamonitor Healthcare report contains a Market Spotlight module.

Indications Covered: Anaplastic Large Cell Lymphoma (ALCL) - NHL
Non-Hodgkin's Lymphoma (NHL)
Peripheral T-Cell Lymphoma (PTCL) - NHL
Back to the top Back to the top